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Centipede
Antimicrobial peptideThe centipede Scolopendra subspinipes mutilans has been amedically important arthropod species by using it as a
traditional medicine for the treatment of various diseases. In this study, we derived a novel lactoferricin B like
peptide (LBLP) from the whole bodies of adult centipedes, S. s. mutilans, and investigated the antifungal effect
of LBLP. LBLP exerted an antifungal and fungicidal activity without hemolysis. To investigate the antifungal
mechanism of LBLP, a membrane study with propidium iodide was ﬁrst conducted against Candida albicans.
The result showed that LBLP caused fungal membrane permeabilization. The assays of the three dimensional
ﬂow cytometric contour plot andmembrane potential further showed cell shrinkage andmembrane depolariza-
tion by the membrane damage. Finally, we conﬁrmed the membrane-active mechanism of LBLP by synthesizing
model membranes, calcein and FITC-dextran loaded large unilamellar vesicles. These results showed that the
antifungal effect of LBLP on membrane was due to the formation of pores with radii between 0.74 nm and
1.4 nm. In conclusion, this study suggests that LBLP exerts a potent antifungal activity by pore formation in the
membrane, eventually leading to fungal cell death.
© 2013 Published by Elsevier B.V.1. Introduction
Antimicrobial peptides (AMPs) are important components of innate
immunity, and their distribution is widespread, including in bacteria,
fungi, plants, insects, birds, crustaceans, amphibians, and mammals [1].
AMPs are typically relatively short (10–50 amino acids), positively
charged (net charge ranging from +2 to +9), and amphiphilic [2].
These characteristics generally allow them to permeabilize bacterial
membranes [3]. However, it has been reported that AMPs with anti-
fungal activity had different mechanisms including membrane
permeabilization, mitochondrial depletion, and depolymerization
of actin cytoskeleton [4]. Chief of all, membrane-permeabilizing
action signiﬁcantly hinders the development of resistance to AMPs
because it is difﬁcult for a microbe to change the lipid composition
of its membrane and this is in marked contrast to conventionaltoferricin B like peptide; SmAE,
merican Type Culture Collection;
inhibitory concentration; PBS,
Standard deviation; DiBAC4(3),
ge unilamellar vesicle; PC, Phos-
atidylinositol; FITC, Fluorescein
82 53 955 5522.
should be considered co-ﬁrst
vier B.V.antibiotics, which usually act by attacking a speciﬁc receptor or en-
zymatic target [5].
Although insecta have been continuously exposed to pathogenic
microorganisms, they make up about 80% of all the animals in the
kingdom Animalia due to remarkable evolutionary success. Therefore,
insects possess potent antimicrobial defense systems and particularly
rely on innate immunity rather than adaptive immunity because of
energy efﬁciency. Among components of innate immunity, AMPs play
important roles in the innate immune systems of invertebrates such
as insects. As a result, a single insect produces approximately 10–15
AMPs upon detection of invading pathogens [6,7]. To date, more than
170 AMPs have been identiﬁed in insects [8]. Melittin, the representa-
tive insect AMP, is the main toxic component in the venom of the
honey bee Apis mellifera. It exerts not only potent antimicrobial activity
but also hemolytic activity by membrane-disruptive action [9–11].
Centipedes have been thought to produce AMPs because they have
only innate immunity [12]. Among them, a big centipede (Scolopendra
subspinipes mutilans) has been used in traditional medicine for the
treatment of various diseases [13]. A few AMPs isolated from the centi-
pede S. s. mutilans have been reported, such as scolopendrin I, scolopin 1
and 2 [12,14,15]. Scolopin 1 and 2 exerted cytotoxicity through hemo-
lytic activities against both human and rabbit erythrocytes. In this
study, a novel lactoferricin B like peptide (LBLP) was derived from the
centipede S. s. mutilans, and its antifungal activities and mechanisms
were investigated. Among tested fungal strains, C. albicans is the fourth
most common cause of hospital-acquired infectious disease and the
primary cause of systemic candidiasis, withmortality rates approaching
Fig. 1. Sequence alignment of LBLP and lactoferricin B.
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experiments of this study.
2. Materials and methods
2.1. Sample collection and treatments
Adult S. s. mutilans were purchased from Jirisan industrial insect
institute in Jinju, South Korea. For infection, log-phase E. coli (2 × 106
colony forming units/centipede) was injected into the body of each
centipede.
2.2. Transcriptomic data analysis
2.2.1. RNA preparation and sequencing
Total RNA samples were prepared from the centipedes using the
RNeasy Total RNA isolation kit (Qiagen, USA) according to the
manufacturer's instructions. Whole body RNA was isolated from E.
coli-infected S. s. mutilans at 18 h after infection. RNA integrity was val-
idated using the Agilent 2100 Bioanalyzer. Beads with Oligo (dT) were
used to isolate poly (A) mRNA. After fragmentation buffer was added
to produce short mRNA fragments, random hexamer-primers were
used to synthesize the ﬁrst-strand cDNA, after which the second-
strand cDNA was synthesized. Short fragments were puriﬁed with the
QIAquick PCR extraction kit and resolved with EB buffer for end repara-
tion and poly (A) addition. The short fragments were tailed with se-
quencing adapters. Fragments suitable for PCR ampliﬁcation were
selected as a template with the agarose gel electrophoresis method. Fi-
nally, the librarywas sequencedwith the IlluminaHiSeq™ 2000 by gen-
erating paired-end libraries with an average insert size of 200 bp,
following the manufacturer's instructions.
2.2.2. Assembly
The S. s. mutilans transcriptome without a reference genome was de
novo assembled using the Trinitymethod [17]. Togetherwith the original
Trinity assembly result, TGICL software was used to obtain sequences
that could not be extended on either end [18]. The resulting sequences,
contigs and singletons, were referred to as S. s. mutilans Assembled
ESTs (SmAEs), sequences of which were translated into amino acid
sequences with ESTScan [19]. 51317 SmAEs were assembled.
2.3. In silico prediction of antimicrobial peptides
2.3.1. Screening based on physicochemical properties
With all of the protein-coding genes collected, potential AMPs were
predicted based on less than or equal to 100 amino acids in length with
EMBOSS PEPSTATS [20]. 52 SmAEs were found.
2.3.2. Novel AMP selection
To predict AMPs based on sequence similarity, BLASTx was
used. The sequences obtained were considered as putative AMPs.Table 1
Amino acid sequence and physicochemical features of LBLP.
Peptide Amino acid sequence Purity Mo
Ca
LBLP RMKKLGNHKVSCERNTKRCRKAI 98.233% 27Among the putative AMPs, we synthesized the following AMP:
LBLP (RMKKLGNHKVSCERNTKRCRKAI).2.4. Solid-phase peptide synthesis
Anygen Co. (Gwangju, Korea) did the peptide synthesis. Anygen Co.
offers the following procedures for peptide synthesis. The assembly of
the peptides was achieved with a 60-min cycle for each residue at
ambient temperature using the following method: (1) 2-chlorotrityl
(or 4-methylbenzhydrylamine amide) resin was charged to a reactor
and then washed with DCM and DMF, respectively, and (2) a coupling
step with vigorous shaking using a 0.14 mM solution of Fmoc-L-amino
acids and Fmoc-L-amino acids preactivated for approximately 60 min
with a 0.1 mM solution of 0.5 M HOBt/DIC in DMF. Finally, the peptide
was cleaved from the resin using a TFA cocktail solution at ambient
temperature [21,22].2.5. Peptide characterization
Analytical and preparative reverse-phase HPLC runs were
performed with Shimadzu 20 A or 6 A gradient systems. Data
were collected with an SPD-20 A detector at 230 nm. Chromato-
graphic separations were achieved with a 1%/min linear gradient
of buffer B in A (A = 0.1% TFA in H2O; B = 0.1% TFA in acetonitrile
(CH3CN)) over 40 min at ﬂow rates of 1 and 8 ml/min using
Shimadzu C18 analytical (5 μm, 0.46 cm × 25 cm) and preparative
C18 (10 μm, 2.5 cm × 25 cm) columns. Mass spectrometry was
also done with AXIMA CFR MALDI TOF Mass Spectrometer
(Kratos/Shimadzu).2.6. Fungal strains and antifungal activity assay
Candida albicans (ATCC 90028) and Candida parapsilosis (ATCC
22019) were obtained from the American Type Culture Collection
(ATCC) (Manassas, VA, USA). Malassezia furfur (KCTC 7744) and
Trichosporon beigelii (KCTC 7707) were obtained from the Korean
Collection for Type Cultures (KCTC) at the Korea Research Institute
of Bioscience and Biotechnology (Daejeon, Korea).
The fungal strains were cultured in YPD broth (Difco) with aeration
at 28 °C, and the M. furfur was cultured at 32 °C in a modiﬁed YM
broth (Difco) containing 1% olive oil. The cell suspensions were adjusted
to obtain standardized populations by measuring the turbidity with a
spectrophotometer (DU530; Beckman, Fullerton, CA, USA). Fungal cells
at the log phase (2 × 106/ml) were inoculated into 0.1 ml/wells of
YPD or YM broth, and then, dispensed tomicrotiter plates. Minimum in-
hibitory concentrations (MICs) were determined with a two-fold serial
dilution of the test peptides, based on the Clinical and Laboratory Stan-
dards Institute (CLSI) method [23]. The MIC values were determined
by three independent assays.lecular mass (MW) Net charge (physiological PH)
lculated value Observed value
57.3 2757.6 +8
Table 2
The antifungal activity of LBLP and melittin.
Fungal strains MIC (μM)
LBLP Melittin
C. albicans ATCC 90028 10.0 5.0
C. parapsilosis ATCC 22019 10.0 2.5–5.0
M. furfur KCTC 7744 10.0–20.0 2.5
T. beigelii KCTC 7707 20.0 5.0
Fig. 2. Time-kill kinetics of 10.0 μM of LBLP and melittin in C. albicans.
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The hemolytic activity of the peptides was evaluated by deter-
mining the release of hemoglobin from a 4% suspension of human
erythrocytes at 414 nm with an ELISA reader. Hemolytic levels of
zero and 100% were determined in phosphate buffered saline (PBS:
35 mM phosphate buffer/150 mM NaCl, pH 7.4) alone and with
0.1% Triton X-100, respectively. The hemolysis percentage was cal-
culated with the following equation: hemolysis (%) = [(Abs414nm
in the peptide solution − Abs414nm in PBS) / (Abs414nm in 0.1% Tri-
ton X-100 − Abs414nm in PBS)] × 100 [24].2.8. Time-kill kinetic analysis
Exponential-phase C. albicans cells (2 × 106/ml YPD) were incubat-
ed with either LBLP or melittin at the MIC. After 2, 4, 6, 8, and 10 h, the
samples were acquired and serially diluted in PBS (pH 7.4). One hun-
dred microliter aliquots were spread onto YPD agar plates, and then
the colony-forming units (CFUs) were counted after incubation for
24 h at 28 °C [25]. The percentage survival was determined relative to
the control treatment. Experiments were performed in triplicate, and
the results were expressed as the mean ± standard deviation (SD).2.9. Analysis of propidium iodide inﬂux, cell size, and cell granularity
C. albicans cells in the log phase (2 × 106/ml YPD), resuspended in
PBS, were treated with 10.0 μM of the peptides and incubated for 4 h
at 28 °C. Cells were harvested by centrifugation and suspended in PBS.
Subsequently, the cells were treated with 9 μM propidium iodide and
incubated for 5 min at room temperature. The cells were analyzed
with a FACSCalibur ﬂow cytometer (Becton Dickinson, San Jose, CA,
USA) [26,27].2.10. Membrane depolarization assay
The log-phased cells of C. albicans (2 × 106/ml YPD) were harvested
and suspended in PBS. After incubationwith 10.0 μMof the peptides for
4 h at 28 °C, the cellswere harvested by centrifugation and resuspended
in PBS. Subsequently, the cells were treated with 50 μg of bis-(1,3-
dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)] (Molecular
Probes, Eugene, OR, USA). Flow cytometric analysis was done with a
FACSCalibur ﬂow cytometer [28]. The histogram is representative of
three separate experiments.Table 3
Hemolytic activity of LBLP and melittin against human erythrocytes.
Peptides Hemolysis (%)
80.0 μM 40.0 μM 20.0 μM 10.0 μM 5.0 μM 2.5 μM 1.3 μM
LBLP 0 0 0 0 0 0 0
Melittin 99.0 91.1 70.2 54.3 23.8 13.3 1.92.11. Calcein leakage measurement
Large unilamellar vesicles (LUVs) encapsulating calcein, composed
of phosphatidylcholine (PC)/phosphatidylethanolamine (PE)/phos-
phatidylinositol (PI)/ergosterol (5:4:1:2, w/w/w/w), were prepared by
vortexing the dried lipids in a dye buffer solution (70 mM calcein,
10 mMTris, 150 mMNaCl, and 0.1 mMEDTA [pH 7.4]). The suspension
was freeze–thawed in liquid nitrogen for 11 cycles and extruded
through polycarbonate ﬁlters (two stacked 200 nm pore size ﬁlters)
with a LiposoFast extruder (Avestin Inc., Ottawa, Canada). Calcein-
entrapped LUVs were separated from free calcein by gel ﬁltration chro-
matography on a Sephadex G-50 column. The leakage of calcein from
the LUVs was monitored at 25 °C by measuring the ﬂuorescence inten-
sity at an excitationwavelength of 490 nmand an emissionwavelength
of 520 nm, with a spectroﬂuorophotometer (Shimadzu RF-5301PC,
Shimadzu, Kyoto, Japan). To determine 100% dye release, 30 μl of 10%
Triton X-100 was added to the vesicles. The percentage of dye leakage
caused by the peptides was calculated as follows: dye leakage (%) =
100 × (F − F0) / (Ft − F0), where F represents the ﬂuorescence inten-
sity achieved after addition of the peptides, and F0 and Ft represent theFig. 3. Flow cytometric analysis of membrane permeabilization detected by propidium
iodide inﬂux assay in C. albicans (2 × 106/ml). The peptides were treated at 10.0 μM.
Fig. 4. (A) Flow cytometric analysis of C. albicans (2 × 106/ml) treatedwith 10.0 μMof the peptides. FSC is an indicator of cell size and SSC (log) is an indicator of cell granularity. (a) Con-
trol, (b) LBLP, and (c)melittin. (B) Flow cytometric analysis of DiBAC4(3) staining inC. albicans (2 × 106/ml) after incubationwith 10.0 μMof the peptides. (a) Control, (b) 10.0 μMof LBLP,
and (c) 10.0 μM of melittin.
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respectively [29]. The data represent themean ± SD for three indepen-
dent experiments.
2.12. Preparation of dextran-loaded liposomes and leakage assay
Fluorescein isothiocyanate (FITC)-labeled dextrans (FD4 and FD10)
were used to evaluate the membrane-active mechanism of LBLP. LUVs
containing FDwere preparedwith the reverse-phase evaporationmeth-
od [30]. To prepare liposomes containing FD, buffer I (1 ml, 50 mMFig. 5. (A) Percentage of calcein leakage from the LUVs [PC:PE:PI:ergosterol = 5:4:1:2 (w/w/w
(10.0, 20.0, 40.0, and 80.0 μM). (B) Percentage of FITC-dextrans (FDs) leakage induced by 10.0potassium phosphate, pH 7.4, with 0.1 mM EDTA), containing 2 mg/ml
of FD, was sonicated (JAC 2010, KODO, Korea) for 30 min with
20 mg/ml of lipid [PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w)] solution
in chloroform on ice. Chloroformwas removed with a rotary vacuum
evaporator for 2 h at 25 °C, resulting ﬁrst in the formation of a
viscous gel and then, a liposome suspension. Buffer I (2 ml) was
added and the suspension was evaporated further for the removal
of eventual traces of chloroform. The liposome suspension was son-
icated, centrifuged, and washed for several cycles at 13,000 rpm for
30 min to remove the unentrapped-FD. For the assay, a suspension/w)] wasmeasured after treatment with the peptides for 10 min at various concentrations
μM of the peptides from PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w) liposomes.
2749H. Choi et al. / Biochimica et Biophysica Acta 1828 (2013) 2745–2750of FD-loaded liposomes was treated with 10 μM of the peptides.
Amolar ratio of peptide:lipidwas 1:50. Themixture (1 ml,ﬁnal volume)
was stirred for 10 min in the dark and then centrifuged at 13,000 rpm
for 20 min. The supernatant was recovered and its ﬂuorescence in-
tensity was recorded at an excitation wavelength of 494 nm and an
emission wavelength of 520 nm with a spectroﬂuorophotometer. The
maximum ﬂuorescence intensity was determined by adding 20 μl of
10% Triton X-100 to a liposome suspension. The percentage of FD leak-
age was calculated the same way as the percentage of calcein leakage.
The data represent themean ± SD for three independent experiments.
3. Results and discussion
3.1. A novel AMP candidate
In order to ﬁnd novel AMPs, a sequential BLASTx search was used
and a peptide with 34.4% sequence similarity to lactoferricin B was
found (Fig. 1). The selected LBLP was synthesized and characterized.
The purity and observed mass of LBLP were 98.233% and 2757.6 Da
(Calculatedmass = 2757.3 Da), respectively. The net charge in physio-
logical PH of LBLP was +8 (Table 1).
3.2. Antifungal and hemolytic activity of LBLP
In this study, the antifungal effects and mechanisms of a novel AMP,
LBLP, derived from the centipede S. s. mutilanswere investigated. Melittin
was used as a positive control peptide for comparing the potency of LBLP.
First, the antifungal activities of LBLP against human pathogenic fungi,
such as C. albicans, C. parapsilosis,M. furfur, and T. beigelii, were examined.
As shown in Table 2, LBLP had antifungal activities, withMIC values in the
range of 10.0–20.0 μM. Melittin, with MIC values in the range of 2.5–
5.0 μM, was more potent than that of LBLP. In the hemolysis assay,
LBLP did not cause hemolysis at any concentration, while melittin
caused 23.8% hemolysis at its MIC value (5.0 μM) against C. albicans.
At the highest concentration (80.0 μM), melittin even showed 99.0%
hemolysis (Table 3). These results suggested that LBLP had remark-
able potential to be considered as a novel AMP for treating fungal
diseases with selective toxicity toward fungal cells over human
erythrocytes.
3.3. Fungicidal activity of LBLP
LBLP exhibited lower MIC against the Candida species than that of
the other strains tested (Table 2). Time-killing assay was conducted
to assess whether LBLP showed fungicidal or fungistatic activity for
C. albicans. The result showed that the activity of LBLP resulted in killing
activity as seen with melittin (Fig. 2). This result indicated that LBLP
exerted candidacidal activities.
3.4. Membrane damage by LBLP
The effect of LBLP on the integrity of fungalmembranes was ﬁrst an-
alyzed by monitoring the inﬂux of propidium iodide. Propidium iodide
only enters membrane-compromised cells and then, intercalates be-
tween bases with guanine and cytosine pairs or with a stoichiometry
of one dye per 4-5 base pairs [31]. If cell membranes were damaged
by LBLP, propidium iodide would diffuse into the cells and bind to the
nucleic acids, exhibiting an increased ﬂuorescence intensity. When
treated with LBLP and melittin, 39.3% and 69.3% of the C. albicans cells
exhibited propidium iodide ﬂuorescence, respectively, thereby indicat-
ing that LBLP caused membrane permeabilization (Fig. 3).
3.5. Cell shrinkage and membrane depolarization by LBLP
Damage to the cytoplasmic membrane of the cell by AMP causes the
loss of the structural and functional integrity of themembrane [32]. Themorphological changes of the cell and function of the membrane are
measurable by ﬂow cytometry. The morphological changes in peptide-
treated C. albicans cells were examined. FSC is an indicator of cell size
and SSC (log) is an indicator of granularity. The result showed that in
the cells treated with LBLP and melittin, 29.3% and 33.0% of cell popula-
tion showed decreased FSC values based onmain population of control,
respectively, which indicates cell shrinkage (Fig. 4A).
To further examine whether LBLP can affect the functions of the
fungal membrane, the changes in membrane potential were detected
with the dye DiBAC4(3). DiBAC4(3) is an anionic lipophilic dye sensitive
to membrane potential and enters only depolarized cells according to
the Nernst equation, where it binds reversibly to lipid-rich intracellular
components [33]. Thus, when the membrane potential decreases,
DiBAC4(3) can penetrate and bind to the hydrophobic core of the lipid
membrane, resulting in an increased ﬂuorescent signal. In cells exposed
to LBLP and melittin, the ﬂuorescence intensity increased 22.4% and
71.2%, respectively, compared to the untreated cells, indicating the de-
polarization of the membrane potential (Fig. 4B). These data strongly
suggested that the fungal membrane was a major target of LBLP. There-
fore, we conﬁrmed that LBLP exerted its antifungal activity by means of
a membrane-active mechanism.
3.6. LBLP-induced pore formation in the fungal membrane
Propidium iodide is also used to detect pore formation [34], and
from the propidium iodide inﬂux by LBLP, we hypothesized that the
membrane-active mechanism of LBLP might be related to pore forma-
tion. To investigate the membrane-active mechanism of LBLP and the
extent of membrane damage induced by the peptides, the leakage
content of different dyes with various molecular weights from artiﬁcial
liposomes was measured, which included calcein (average molecular
weight = 623 Da, Stokes–Einstein radius = 0.74 nm) [35], FD4 (aver-
age molecular weight = 4 kDa, Stokes–Einstein radius = 1.4 nm) and
FD10 (average molecular weight = 10 kDa, Stokes–Einstein radius =
2.3 nm) [36]. The LUV resembled the outer leaﬂets of the plasma mem-
brane of C. albicans composed of PC/PE/PI/ergosterol (5:4:1:2,w/w/w/w)
[37]. The results showed that LBLP induced dose-dependent calcein leak-
age at all the tested concentrations. The 10.0 μM of LBLP and Melittin
caused 44.5% and 55.1% calcein leakage from the LUVs, respectively
(Fig. 5A). In the FD leakage assay, melittin induced the release of FD4
and FD10, suggesting the size of the pore formed by melittin was larger
than 2.3 nm. However, LBLP did not cause the release of the FDs from
the liposomes at all (Fig. 5B). This resultmeans that LBLP induced forma-
tion of pores with radii between 0.74 nm and 1.4 nm. Taken together,
these results showed that LBLP formed pores resulting in an increased
permeability of the fungal membrane. Hence, the fungal cells experi-
enced membrane depolarization which causes a loss of ions, and then
LBLP eventually led to fungal cell death and cell shrinkage.
In conclusion, LBLP, a novel AMP, exerted remarkable antifungal
activities, especially against Candida species, without hemolysis. The
antifungal effects through the pore-forming action of LBLP ultimately
resulted in fungal cell death.
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